Cannabis Report text across cannabis leaves.
(File image)

A top North American cannabis company signed an exclusive licensing agreement with Tyson 2.0, legendary boxer Mike Tyson’s cannabis brand, to launch its product portfolio in Maryland and Pennsylvania beginning in 2026. TerrAscend will manufacture and distribute flower, vapes and edibles in Maryland, while offering flower, vapes, concentrates and troches through its Apothecarium dispensaries and wholesale network in Pennsylvania.

Tyson 2.0 cannabis products mock up. (Source: Google Gemini. Generated by AI)

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | Cannara Biotech delivers record fiscal 2025 revenue and profitability, achieves first year of positive retained earnings

2 | Glow Lifetech reports record Q3 2025 financial results; 193 per cent YoY revenue growth and achieves first positive cash flow from operations

3 | Tilray Brands announces implementation of 1-for-10 reverse stock split

4 | Good Supply vapes arrive in Québec following the recent introduction of vape products in the province


Top Cannabis Stocks Nov. 20 to Nov. 27, 2025

1. T.TLRY | 4,1334 views | Tilray Brands Inc.
2. T.LABS | 3,698 views | Medipharm Labs Corp.
3. T.CURA | 3,543 views | Curaleaf Holdings Inc.
4. T.WEED | 1,454 views | Canopy Growth Corp.
5. C.TGIF | 483 views | 1933 Industries Inc.
6. T.OGI | 432 views | Organigram Global Inc.


Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.


More From The Market Online

@ the Bell: TSX reaches new highs despite oil weakness

Despite a muted performance among the broader market, the TSX climbed to a new historic high...

Alchemy signs development deal to camouflage Canadian troops

Alchemy Labs signs a contract to deploy its Crypsis thermal signature management technology into products for the Canadian defense market.
Heart scans using Ventripoint Diagnostic's VMS+ technology

Ventripoint broadens access to AI cardiac imaging

Ventripoint (TSXV:VPT) is expanding access to its AI-powered cardiac imaging platform to help hospitals adopt the it without large costs.
TSX and Nasdaq rise as Nebius jumps on AI demand. Air Canada cuts guidance, Cerebras falls, oil drops, gold slips and Bitcoin edges higher.

Market Open: Nebius Soars on AI Demand, Air Canada Cuts Guidance as Fuel Costs Bite | Aug 13th

TSX and Nasdaq rise as Nebius jumps on AI demand. Air Canada cuts guidance, Cerebras falls, oil drops, gold slips and Bitcoin edges higher.